Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals manufactures specialty products and diagnostics

Based in MO

🤖

AI Overview

With $1.4M in lobbying spend across 18 quarterly filings, Mallinckrodt Pharmaceuticals is a significant lobbying presence.

$1.4M
Total Lobbying Spend
18
Quarterly Filings
1
Lobbying Firms Used
9
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$240K
2019$240K
2020$320K
2021$320K
2022$260K

Lobbying Firms

TARPLIN, DOWNS & YOUNG, LLC

What They Lobby For

  • prescription drug abuse and deterrence, non-interference PL 114-255 - 21st Century Cures, implementation Multi-modal analgesics S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 469 - Affordable and Safe Prescription Drug Importation act H.R. 749 - Lower Drug Costs Through Competition Act H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 3921 - Healthy Kids Act S. 1827 - Kids Act of 2017 S. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 6 - SUPPORT for Patients and Communities Act S. 3120 - HEAL Substance Use Disorders Act S. 2680 - Opioid Crisis Response Act S. 2852 - Pandemic and All Hazards Preparedness Act
  • H.R. 1- Tax Cuts and Jobs Act
  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018
  • prescription drug abuse and deterrence, non-interference PL 114-255 - 21st Century Cures, implementation Multi-modal analgesics S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 469 - Affordable and Safe Prescription Drug Importation act H.R. 749 - Lower Drug Costs Through Competition Act H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 3921 - Healthy Kids Act S. 1827 - Kids Act of 2017 S. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 6 - SUPPORT for Patients and Communities Act S. 3120 - HEAL Substance Use Disorders Act S. 2680 - Opioid Crisis Response Act S. 2852 - Pandemic and All Hazards Preparedness Act S. 3282 - DEA Clearinghouse Act of 2018
  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 H.R. 6157 - HHS appropriations and continuing resolution
  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 H.R. 6157 - HHS appropriations and continuing resolution H.R. 695 - Department of Defense Appropriations Act
  • Medicaid drug rebate program
  • prescription drug abuse and deterrence, non-interference, opioids H.R. 269 - PAHPA Reauthorization of 2019 no specific bills, drug pricing and innovation
  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.J.Res. 31 - Consolidated Appropriations Act, 2019
  • debt ceiling, appropriations H.R. 2740 - HHS Appropriations, 2020 H.R. 3164 - FDA Appropriations, 2020 H.R. 4378 - Continuing Appropriations Act and Health Extenders Act

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.